参考文献/References:
[1] Solomon DA,Kim JS,Cronin JC,et al.Mutational inactivation ofPTPRD in glioblastoma multiforme and malignant melanoma[J].Cancer Res,2008,68(24):10300-10306.
[2] Cox,C,Bignell G,Greenman C,et al.A survey of homozygous deletions inhuman cancer genomes[J].Proc Natl Acad Sci USA,2005,102(12):4542-4547.
[3] Sato M,Takahashi K,Nagayama K,et al.Identification of chromosome arm9p as the most frequent target of homozygous deletions in lung cancer[J].Genes Chromosomes Cancer,2005,44(4):405-414.
[4] Stallings RL,Nair P,Maris JM,et al.High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumorsuppressor gene in neuroblastoma[J].Cancer Res,2006,66(7):3673-3680.
[5] Stark M,Hayward N.Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays[J].Cancer Res,2007,67(6):2632-2642.
[6] Purdie KJ,Lambert SR,Teh MT,et al.Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected usingsingle nucleotide polymorphism microarray analysis[J].Genes Chromosomes Cancer,2007,46(7):661-669.
[7] Nagayama K,Kohno T,Sato M,et al.Homozygous deletion scanning of the lung cancer genome at a 100-kb resolution[J].Genes Chromosomes Cancer,2007,46(11):1000-1010.
[8] Weir BA,Woo MS,Getz G,et al.Characterizing the cancer genome in lungadenocarcinoma[J].Nature,2007,450(7171):893-898.
[9] Sjoblom T,Jones S,Wood LD,et al.The consensus coding sequences of human breast and colorectal cancers[J].Science,2006,314(5797):268-274.
[10] Veeriah S,Brennan G,Meng S,et al.The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers[J].Proc Natl Acad Sci U S A,2009,106(23):9435-9440.
[11] Chan TA,Glockner S,Yi JM,et al.Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis[J].PLoS Med,2008,5(5):e114.
[12] Iwasa S,Jin X,Okada K,et al.Increased expression of seprase,a membrane-type serine protease,is associated with lymph node metastasis inhuman colorectal cancer[J].Cancer Lett,2005,227(2):229-236.
[13] Guo Y,Chen Z,Zhang L,et al.Distinctive microRNA profiles relating topatient survival in esophageal squamous cell carcinoma[J].Cancer Res,2008,68(1):26-33.
[14] 杜华阳,李秀娟,范 婕,等.Oct4和Sox2在食管鳞癌组织中的表达及相关性探讨[J].河北北方学院学报(自然科学版),2015,31(1):71-74.
Du HY,Li XJ,Fan J,et al.Expressions of Oct4 and Sox2 protein and their correlations in esophageal squamous cell carcinoma[J].Journal of Hebei North University(Natural Science Edition),2015,31(1):71-74.
[15] 陈斯泽,李玉齐,杨 曙,等.HSP90抑制剂对食管鳞癌细胞株TE-1凋亡的影响及作用机制[J].分子影像学杂志,2015,38(3):186-189.
Chen SZ,Li YQ,Yang S,et al.Effect of HSP90 inhibitor on apoptosis in esophageal squamous carcinoma cell TE-1 and its mechanism[J].Journal of Melecular Jmaging,2015,38(3):186-189.
[16] 陆寓非,郑晓丽,杨成梁,等.RNAiSurvivin基因表达对食管鳞癌细胞的影响[J].医药论坛杂志,2015,36(9):39-40.
Lu YF,Zheng XL,Yang CL,et al.Effects of eso-phageal squamous carcinoma by survivin gene with RNA interference[J].J Medical Fourn,2015,36(9):39-40.
[17] 姚宁华,盖 领,黄 华,等.FoxQ1在食管鳞状细胞癌中的表达及其与预后[J].临床与病理杂志,2015,35(9):1632-1636.
Yao NH,Gai L,Huang H,et al.Expression and prognosis of FoxQ1 in esophageal squamous cell carcinoma[J].International Journal of Pathology and ClinicalMedicine,2015,35(9):1632-1636.
[18] Pulido R,Serra-Pages C,Tang M,et al.The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-tyrosine-phosphatases:multiple human LAR,PTPdelta,and PTP sigma isoforms are expressed in a tissue-specific manner and associate with the LAR-interacting protein LIP.1[J].Proc Natl Acad Sci USA,1995,92(25):11686-11690.
[19] Tonks NK.Protein tyrosine phosphatases:from ge-nes,to function,to disease[J].Nat Rev Mol Cell Biol,2006,7(11):833-846.
[20] Ostman A, Hellberg C, Bohmer FD.Protein-tyrosine phosphatases and cancer[J].Nat Rev Cancer,2006,6(4):307-320.
[21] Hunter T,Signaling-2000 and beyond[J].Cell,20 00,100(1):113-127.
[22] Solomon DA,Jung-sik K,Cronin JC,et al.Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma[J].Cancer Res,2008,68(24):10300-10306.
[23] Veeriah S,Brennan C,Meng S,et al.The tyrosine phosphatase PTPRD is atumor suppressor that is frequently inactivated and mutated in glioblastoma andother human cancers[J].Proc Natl Acad Sci USA,2009,106(23):9435-9440.
相似文献/References:
[1]王静,王成,张春妮.血清miR-25和miR-100作为食管鳞状细胞癌诊断和预后标志物研究[J].现代检验医学杂志,2015,30(05):17.[doi:10.3969/j.issn.1671-7414.2015.05.006]
WANG Jing,WANG Cheng,ZHANG Chun-ni.Study on Serum miR-25 and miR-100 as Diagnostic and
Prognostic Markers for Esophageal Squamous Cell Carcinoma[J].Journal of Modern Laboratory Medicine,2015,30(01):17.[doi:10.3969/j.issn.1671-7414.2015.05.006]
[2]贾亚旭,王 成,张春妮.血清miR-193a-3p,miR-337-5p和miR-483-5p在食管鳞状细胞癌诊断和预后中的应用[J].现代检验医学杂志,2017,32(02):5.[doi:10.3969/j.issn.1671-7414.2017.02.002]
JIA Ya-xu,WANG Cheng,ZHANG Chun-ni.Application of Serum miR-193a-3p,miR-337-5p and miR-483-5p
in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma[J].Journal of Modern Laboratory Medicine,2017,32(01):5.[doi:10.3969/j.issn.1671-7414.2017.02.002]
[3]徐 超,徐 珊,窦 燕,等.食管鳞状细胞癌组织PTOV1，IGBP1的表达与临床病理特征和预后相关性研究[J].现代检验医学杂志,2022,37(03):100.[doi:10.3969/j.issn.1671-7414.2022.03.021]
[4]李智军a,姜海燕b,边 超a,等.LINC01503 调控ERK 磷酸化促进食管鳞状细胞癌放疗抵抗的机制研究[J].现代检验医学杂志,2023,38(02):25.[doi:10.3969/j.issn.1671-7414.2023.02.005
]
LI Zhi-juna,JIANG Hai-yanb,BIAN Chaoa,et al.Mechanism of LINC01503 Promotes Radiotherapy Resistance to Esophageal Squamous Cell Carcinoma by Regulating ERK Phosphate Acidization[J].Journal of Modern Laboratory Medicine,2023,38(01):25.[doi:10.3969/j.issn.1671-7414.2023.02.005
]
[5]钟守平,胡艳正.食管鳞状细胞癌组织中组织定居记忆T细胞分布浸润特征及与免疫治疗预后的关系研究[J].现代检验医学杂志,2025,40(02):11.[doi:10.3969/j.issn.1671-7414.2025.02.003]
ZHONG Shouping,HU Yanzheng.Study on the Distribution and Infiltration Characteristics of Tissue Resident Memory T Cells in Esophageal Squamous Cell Carcinoma and Its Relationship with Immunotherapy Prognosis[J].Journal of Modern Laboratory Medicine,2025,40(01):11.[doi:10.3969/j.issn.1671-7414.2025.02.003]